PLoS ONE (Jan 2020)

Novel CRISPR-based sequence specific enrichment methods for target loci and single base mutations.

  • Jennifer L Steele,
  • Richard C Stevens,
  • Oscar A Cabrera,
  • Gary J Bassill,
  • Sabrina M Cramer,
  • Felipe Guzman,
  • Anthony P Shuber

DOI
https://doi.org/10.1371/journal.pone.0243781
Journal volume & issue
Vol. 15, no. 12
p. e0243781

Abstract

Read online

The programmable sequence specificity of CRISPR has found uses in gene editing and diagnostics. This manuscript describes an additional application of CRISPR through a family of novel DNA enrichment technologies. CAMP (CRISPR Associated Multiplexed PCR) and cCAMP (chimeric CRISPR Associated Multiplexed PCR) utilize the sequence specificity of the Cas9/sgRNA complex to target loci for the ligation of a universal adapter that is used for subsequent amplification. cTRACE (chimeric Targeting Rare Alleles with CRISPR-based Enrichment) also applies this method to use Cas9/sgRNA to target loci for the addition of universal adapters, however it has an additional selection for specific mutations through the use of an allele-specific primer. These three methods can produce multiplex PCR that significantly reduces the optimization required for every target. The methods are also not specific to any downstream analytical platform. We additionally will present a mutation specific enrichment technology that is non-amplification based and leaves the DNA in its native state: TRACE (Targeting Rare Alleles with CRISPR-based Enrichment). TRACE utilizes the Cas9/sgRNA complex to sterically protect the ends of targeted sequences from exonuclease activity which digests both the normal variant as well as any off-target sequences.